A recent study conducted by Meyer Vitabiotics, an Indian nutraceutical major, has uncovered the potential of antioxidant micronutrients and vitamins in improving male fertility. The research involved 300 Indian males with various types and degrees of infertility and tested the effectiveness of Oligocare Forte Plus, a supplement containing a mix of multi-vitamins, minerals, essential amino acids, ginseng, and lycopene. The results revealed a 75.76% increase in sperm count among participants with a baseline sperm count of less than 5 million/ml.
The trial sought to explore the efficacy of antioxidant therapy for male infertility, with a focus on improving semen parameters and the DNA Fragmentation Index (DFI). Antioxidants frequently prescribed for treating male infertility include vitamins E and C, carnitine, N-acetyl cysteine, selenium, and zinc. The Oligocare Forte Plus tablet, also known as Wellman Conception in the UK, combines these essential micronutrients, amino acids, antioxidants, and vitamins crucial for male reproductive health.
Infertility is a significant global concern, with male infertility accounting for 20-30% of total cases. Male factor infertility is often linked to abnormalities in semen parameters, such as Oligospermia, Asthenozoospermia, and Teratozoospermia. Existing treatment options, such as surgery, hormonal therapy, and drug therapy, are often associated with higher costs, uncertain clinical effectiveness, and side effects.
Antioxidants have gained increasing interest among clinicians and researchers for boosting parameters of male fertility. The Meyer Vitabiotics study offers a new perspective on male infertility treatment, showcasing the potential of antioxidant micronutrient therapy as a more accessible, cost-effective, and clinically efficient alternative to current options.
The uniqueness of this trial lies in the inclusion of DFI as an assessment factor before and after the treatment, providing valuable insights into the impact of antioxidant therapy on male fertility. The promising results from Meyer Vitabiotics’ study highlight the potential of multi-micronutrient therapy for addressing male infertility, offering a new direction for future research and treatment.
